Katherine D LaGuardia Selected Research

ethinyl estradiol drug combination norgestimate (Ortho Tri-Cyclen)

12/2009	Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial.
7/2003	Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
6/2003	Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katherine D LaGuardia Research Topics

Disease

4	Hemorrhage 12/2009 - 06/2003
2	Body Weight (Weight, Body) 06/2009 - 11/2007
2	Metrorrhagia (Spotting) 07/2003 - 06/2003
1	Body Weight Changes 11/2007
1	Headache (Headaches) 06/2005

Drug/Important Bio-Agent (IBA)

3	ethinyl estradiol drug combination norgestimate (Ortho Tri-Cyclen)FDA LinkGeneric 12/2009 - 06/2003
3	Oral ContraceptivesIBA 12/2009 - 11/2007
2	Contraceptive Agents (Contraceptives)IBA 08/2009 - 06/2005
1	norgestimate FDA LinkGeneric 12/2009
1	drospirenone FDA LinkGeneric 12/2009
1	Norethindrone Acetate (Norlutate)FDA LinkGeneric 11/2007
1	Ortho Evra (Evra)FDA Link 06/2005
1	Estrogens (Estrogen)FDA Link 06/2005
1	norelgestromin (LNGO)FDA Link 06/2005
1	Hormones (Hormone)IBA 06/2005
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 06/2005
1	ferrous fumarate drug combination ethinyl estradiol norethindrone acetate (Zoran)IBA 07/2003

Therapy/Procedure

1	Contraception (Birth Control) 06/2005